Literature DB >> 31267160

Impact of DNA degradation on massively parallel sequencing-based autosomal STR, iiSNP, and mitochondrial DNA typing systems.

Elena I Zavala1, Swetha Rajagopal2,3, George H Perry4, Ivana Kruzic5, Željana Bašić5, Thomas J Parsons6, Mitchell M Holland2.   

Abstract

Biological samples, including skeletal remains exposed to environmental insults for extended periods of time, exhibit increasing levels of DNA damage and fragmentation. Human forensic identification methods typically use a combination of mitochondrial (mt) DNA sequencing and short tandem repeat (STR) analysis, which target segments of DNA ranging from 80 to 500 base pairs (bps). Larger templates are often unavailable as skeletal samples age and the associated DNA degrades. Single-nucleotide polymorphism (SNP) loci target shorter templates and may serve as a solution to the problem. Recently developed assays for STR and SNP analysis using a massively parallel sequencing approach, such as the ForenSeq kit (Verogen, San Diego, CA), offer a means for generating results from degraded samples as they target templates down to 60 to 170 bps. We performed a modeling study that demonstrates that SNPs can increase the significance of an identification when analyzing DNA down to an average size of 100 bps for input amounts between 0.375 and 1 ng of nuclear DNA. Observations from this study were then compared with human skeletal material results (n = 14, ninth to eighteenth centuries), which further demonstrated the utility of the ForenSeq kit for degraded samples. The robustness of the Promega PowerSeq™ Mito System was also tested with human skeletal remains (n = 70, ninth to eighteenth centuries), resulting in successful coverage of 99.29% of the mtDNA control region at 50× coverage or more. This was accompanied by modifications to a mainstream DNA extraction technique for skeletal remains that improved recovery of shorter templates.

Entities:  

Keywords:  Fragmented DNA; Massively parallel sequencing; SNPs; STRs

Mesh:

Substances:

Year:  2019        PMID: 31267160     DOI: 10.1007/s00414-019-02110-4

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  5 in total

1.  Multiple methods used for type detection of uniparental disomy in paternity testing.

Authors:  Hongliang Su; Tingting Sun; Man Chen; Jinding Liu; Xiao Wang; Yaming Chen; Wenyan Ren; Gengqian Zhang; Jiangwei Yan; Keming Yun
Journal:  Int J Legal Med       Date:  2019-12-06       Impact factor: 2.686

2.  Massively parallel sequencing of human skeletal remains in Vietnam using the precision ID mtDNA control region panel on the Ion S5™ system.

Authors:  May Thi Anh Ta; Nam Ngoc Nguyen; Duc Minh Tran; Trang Hong Nguyen; Tuan Anh Vu; Dung Thi Le; Phuong Thi Le; Thu Thi Hong Do; Ha Hoang; Hoang Ha Chu
Journal:  Int J Legal Med       Date:  2021-07-01       Impact factor: 2.686

3.  A Forensic Genomics Approach for the Identification of Sister Marija Crucifiksa Kozulić.

Authors:  Charla Marshall; Kimberly Sturk-Andreaggi; Erin M Gorden; Jennifer Daniels-Higginbotham; Sidney Gaston Sanchez; Željana Bašić; Ivana Kružić; Šimun Anđelinović; Alan Bosnar; Miran Čoklo; Anja Petaros; Timothy P McMahon; Dragan Primorac; Mitchell M Holland
Journal:  Genes (Basel)       Date:  2020-08-14       Impact factor: 4.096

4.  Isometric artifacts from polymerase chain reaction-massively parallel sequencing analysis of short tandem repeat loci: An emerging issue from a new technology?

Authors:  Irena Zupanič Pajnič; Carlo Previderè; Tomaž Zupanc; Martina Zanon; Paolo Fattorini
Journal:  Electrophoresis       Date:  2022-05-11       Impact factor: 3.595

5.  Ancient DNA Methods Improve Forensic DNA Profiling of Korean War and World War II Unknowns.

Authors:  Elena I Zavala; Jacqueline Tyler Thomas; Kimberly Sturk-Andreaggi; Jennifer Daniels-Higginbotham; Kerriann K Meyers; Suzanne Barrit-Ross; Ayinuer Aximu-Petri; Julia Richter; Birgit Nickel; Gregory E Berg; Timothy P McMahon; Matthias Meyer; Charla Marshall
Journal:  Genes (Basel)       Date:  2022-01-11       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.